This is a medication used to prevent blood clots in people with certain heart conditions. It helps stop the blood from clumping together, which can reduce the risk of heart attack or stroke. It's often used before or during certain heart procedures.
Every report comes from a Lived member, sent anonymously.
Have you tried Effient (Prasugrel) for Heart Attack?
Prasugrel, sold under the brand name Effient and as a generic, is a prescription antiplatelet medicine. It is used after an acute coronary syndrome, meaning a heart attack or unstable angina (chest pain caused by a sudden shortage of blood flow to the heart), when the blocked artery is treated with percutaneous coronary intervention (PCI). PCI is the catheter procedure, often called angioplasty, that opens a narrowed heart artery and usually props it open with a small mesh tube called a stent. Taken together with aspirin, prasugrel lowers the chance of another heart attack or a clot forming inside the new stent. In the main trial that led to its approval, it prevented more heart attacks than clopidogrel (Plavix), an older medicine that works in a similar way, but it also caused more serious bleeding. It is not used when an acute coronary syndrome is managed without PCI, and it is not an option for anyone who has had a stroke or a mini-stroke. Ticagrelor (Brilinta) is another medicine used in the same role, so the choice among these three depends on a person's bleeding risk, age, weight and medical history.
Platelets are small blood cells that clump together to seal a wound. Inside a narrowed or freshly stented heart artery, that same clumping can build a clot that blocks blood flow and causes a heart attack. One of the signals that tells platelets to clump is a chemical called adenosine diphosphate (ADP), which acts on a receptor on the platelet surface known as P2Y12. Prasugrel is a prodrug: the body converts it into an active form, which attaches permanently to the P2Y12 receptor and switches it off. After the first large dose, most people have substantial platelet blocking within about an hour. Because the attachment is permanent, each affected platelet stays less sticky for the rest of its life, roughly 7 to 10 days. The effect therefore fades only as the body makes new platelets, over about 5 to 9 days after the last dose, and simply skipping a dose does little to lower bleeding risk before a procedure. Prasugrel helps prevent new clots; it does not dissolve a clot that has already formed.
Prasugrel comes as 5 mg and 10 mg tablets. Treatment starts with a single 60 mg loading dose, usually given in the hospital around the time of the heart procedure, followed by 10 mg once a day. For people who weigh less than 60 kg (about 132 pounds), the prescriber may choose 5 mg a day instead, because lighter people are exposed to more of the active drug and bleed more often; the 5 mg dose has not been directly tested for how well it prevents heart events. Prasugrel is taken with daily aspirin at the dose the care team recommends, and it can be taken with or without food. Do not split or break the tablets, and keep them in the original bottle with the drying packet inside. If a dose is missed, take it when remembered unless the next dose is nearly due; do not take two doses together. The most important instruction is not to stop prasugrel on your own, even for a few days, without talking to the doctor who prescribed it. Stopping too early, especially in the first weeks after a heart attack or stent, raises the risk of a clot in the stent, another heart attack and death. If another doctor or a dentist suggests stopping it, they should speak with the prescriber first.
Bleeding is the main side effect. People taking prasugrel bruise more easily, get more nosebleeds and find that small cuts take longer to stop bleeding. In the main trial, serious bleeding was more common than with clopidogrel, and the risk was highest in the first days of treatment. Prasugrel carries an FDA boxed warning, the agency's most prominent kind, that it can cause significant and sometimes fatal bleeding. Other complaints reported in trials, such as headache, back pain, nausea, dizziness and shortness of breath, occurred about as often as with clopidogrel. Call the care team right away for bleeding that is unexpected or lasts a long time, pink or brown urine, red or black tarry stools, coughing up blood, vomit that contains blood or looks like coffee grounds, or bruises that appear without a reason or keep growing. Also call promptly after a fall or injury, especially if you hit your head, even if you feel fine. Bleeding that is heavy or will not stop needs urgent medical evaluation. Two rarer reactions need immediate attention. Thrombotic thrombocytopenic purpura (TTP) is a serious disorder in which small clots form throughout the body and use up platelets; it can appear within the first two weeks. Signs include purple spots on the skin or inside the mouth, yellowing of the skin or eyes, unusual paleness or weakness, fever, confusion or speech changes, and reduced or pink-tinged urine, and it needs hospital treatment right away. A severe allergic reaction, such as swelling of the face, lips or throat or trouble breathing or swallowing, is an emergency, and it can occur in people who have reacted to clopidogrel before. Sudden slurred speech, sudden weakness or numbness in one part of the body, sudden blurry vision or a sudden severe headache can mean a stroke, including bleeding in the brain. Call 911 right away.
Prasugrel is not used in people who are actively bleeding, for example from a stomach ulcer or inside the skull, or who have ever had a stroke or a transient ischemic attack (TIA, a mini-stroke whose symptoms pass). In the main trial, people with a past stroke or TIA had more strokes on prasugrel, including brain bleeds, than on clopidogrel. For people aged 75 or older, prasugrel is generally not recommended, because fatal bleeding and bleeding in the brain were more common and the benefit was uncertain. It may still be considered for people in that age group who have diabetes or a previous heart attack, where the benefit appeared larger. Low body weight, recent injury or surgery, past stomach or bowel bleeding, severe liver disease and moderate to severe kidney disease also raise bleeding risk. Other medicines that affect clotting add to that risk. These include warfarin and other anticoagulants (blood thinners that slow the clotting process), heparin, and regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Tell the prescriber and pharmacist about every prescription, over-the-counter medicine and supplement, and check before adding a new one. Surgery and dental work need planning. Prasugrel is not started when urgent heart bypass surgery is likely, because bypass surgery soon after prasugrel carries a much higher risk of heavy bleeding. When possible, it is stopped at least 7 days before a planned operation, but only on the prescriber's instructions, since stopping also raises the risk of a stent clot. Tell every surgeon and dentist that you take it. There is no human information on prasugrel in pregnancy or breastfeeding. Because of its bleeding risk, anyone who is pregnant, planning a pregnancy or breastfeeding should discuss the benefits and risks with the care team.
Prasugrel starts blocking platelets within hours, but there is nothing to feel when it works. Its value lies in heart attacks and stent clots that do not happen. In the main trial, the advantage over clopidogrel appeared within the first few days and held through about 15 months of follow-up. Prasugrel is usually given as part of dual antiplatelet therapy, meaning aspirin plus a medicine like prasugrel. The best length of treatment is not settled. Recent guidelines suggest about 6 to 12 months for people at higher risk of clots and lower risk of bleeding, and a shorter course followed by a single antiplatelet medicine for people at higher risk of bleeding. Some people are later switched to clopidogrel, a less potent option, to reduce bleeding. The cardiologist sets the plan and reviews it at follow-up visits, where bleeding, new medicines, upcoming procedures and changes in health are discussed. Prasugrel is one part of care after a heart attack, alongside other long-term medicines such as a statin and changes that lower heart risk.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Effient (Prasugrel), what you've noticed, or ask the community a question.